Talzenna Capsule, Liquid Filled
Product Images NDC 0069-0546

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Talzenna (NDC 0069-0546). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Talzenna 01)

Chemical structure diagram of talazoparib, the active ingredient in Talzenna capsules, showing its molecular composition including fluorine, nitrogen, and other elements, alongside an associated sulfonic acid group structure.*

FDA Label Image

Figure 1 (Talzenna 02)

A Kaplan-Meier curve showing progression-free survival probability (%) over time in months for two groups: Talzenna and Chemotherapy. The solid line represents Talzenna and the dashed line represents Chemotherapy, with Talzenna showing higher survival probabilities over time. Below the graph is a table listing the number of patients at risk in each group at multiple time points.*

FDA Label Image

Figure 2 (Talzenna 03)

A Kaplan-Meier overall survival probability curve comparing Talzenna (talazoparib) and chemotherapy over 60 months. The x-axis represents time in months, and the y-axis shows overall survival probability percentage. The chart includes the number of patients at risk for both Talzenna and chemotherapy groups at various time points.*

FDA Label Image

Figure 3 (Talzenna 03a)

A Kaplan-Meier survival curve showing progression-free survival probability (%) over time in months. The chart compares two treatment groups: TALZENNA plus Enzalutamide and Placebo plus Enzalutamide. Below the x-axis is a table showing the number of patients at risk over time for each group.*

FDA Label Image

Logo (Talzenna 04)

FDA Label Image

Logo (Talzenna 04a)

FDA Label Image

Principal Display Panel (0.1 mg Capsule Bottle Label)

Label for Talzenna 0.1 mg capsules containing talazoparib, an oral prescription drug by Pfizer Laboratories Div Pfizer Inc. The package includes 30 liquid-filled capsules. The label includes storage instructions, dosage reference to prescribing information, and distribution details stating it is made in Germany.*

FDA Label Image

Principal Display Panel (0.25 mg Capsule Bottle Label)

Label for Talzenna (talazoparib) oral capsules, strength 0.25 mg, containing 30 capsules per package. The label shows the Pfizer logo and states the product is distributed by Pfizer Laboratories Division of Pfizer Inc. It includes storage instructions and notes the capsules are made in Germany. This is a prescription drug label with a barcode and NDC 0069-0353-30.*

FDA Label Image

Principal Display Panel (0.35 mg Capsule Bottle Label)

Label for Talzenna (talazoparib) capsules, 0.35 mg strength. The label shows a 30-capsule package, oral liquid-filled capsules by Pfizer Laboratories Division of Pfizer Inc. It includes storage instructions, dosage reference, manufacturer information, and a barcode.*

FDA Label Image

Principal Display Panel (0.5 mg Capsule Bottle Label)

Talzenna (talazoparib) capsules 0.5 mg label for a bottle containing 30 capsules. The label includes storage instructions, dosage reference, distributor information by Pfizer Labs Division of Pfizer Inc., and notes the product is made in Germany. The label also displays the Pfizer logo, NDC 0069-0546-30, and a barcode.*

FDA Label Image

Principal Display Panel (0.75 mg Capsule Bottle Label)

Talzenna 0.75 mg capsules label showing the brand name, generic name talazoparib, and strength. The packaging notes 30 capsules per container, manufacturer Pfizer Laboratories Division of Pfizer Inc., and indicates the product is prescription only. Storage instructions and manufacturing origin, Germany, are also visible.*

FDA Label Image

Principal Display Panel (1 mg Capsule Bottle Label)

Talzenna (talazoparib) capsules 1 mg oral dosage form in a package containing 30 capsules. The label shows the Pfizer logo and indicates the product is Rx only. Storage instructions specify 20°C to 25°C with permitted excursions. The label notes the product is made in Germany and distributed by Pfizer Labs Division of Pfizer Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.